MS vs PG: Which Is the Better Buy?
Side-by-side comparison of Morgan Stanley and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
Morgan Stanley · Financial Services
$218.37
+45.0% upside to fair value
Grade B
High Quality
VS
The Procter & Gamble Company · Consumer Defensive
$150.38
+10.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
MS has more upside to fair value
(+45.0%).
PG trades at a lower forward P/E
(21.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MS |
PG |
| Current Price |
$218.37 |
$150.38 |
| Fair Value Estimate |
$316.64 |
$165.39 |
| Upside to Fair Value |
+45.0%
|
+10.0%
|
| Market Cap |
$344.4B |
$350.2B |
| Forward P/E |
23.6x
|
21.5x
|
| EV / EBITDA |
9.8x
|
15.1x
|
| Price / Sales |
2.7x
|
4.0x
|
| Price / FCF |
-327.4x
|
23.3x
|
| Revenue Growth YoY |
+22.4%
|
+7.4%
|
| Gross Margin |
56.6%
|
50.3%
|
| Operating Margin |
28.4%
|
23.2%
|
| Return on Equity |
23.4%
|
31.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
4.29%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Morgan Stanley is a leading global financial services firm specializing in capital markets, wealth management, and investment banking. The company demonstrates high business quality with a strong return on equity of 23.4% and robust revenue growth of 22.4% in the most recent quarter, alongside impressive earnings growth of 57.7% in the same period. Its gross margin of 56.6% and net margin of 20.2…
The Procter & Gamble Company is a leading global consumer defensive company specializing in household and personal products with a strong portfolio across fabric care, baby and family care, beauty, health care, and grooming. The business quality is high, supported by a durable competitive moat from strong brands, consistent earnings growth, and prudent capital allocation emphasizing dividends and…
Accumulation Zones
| Metric |
MS |
PG |
| Zone Low |
$237.48 |
$124.04 |
| Zone High |
$269.14 |
$140.58 |
| In Buy Zone? |
Yes
|
No
|